查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1710217

2025年全球藥物傳輸設備市場報告

Drug And Gene Delivery Devices Global Market Report 2025
出版日期: | 出版商: The Business Research Company | 英文 200 Pages | 商品交期: 2-10個工作天內

價格
簡介目錄

預計未來幾年藥物傳輸裝置市場規模將強勁成長。到 2029 年，這一數字將成長至 9.3 億美元，複合年成長率為 8.7%。預測期內的成長歸因於慢性病患病率的不斷上升、對個性化醫療的需求不斷成長、對基因治療的認知和採用不斷提高、對非侵入性和微創手術的需求以及直接面向患者的治療模式的日益普及。預測期內的關鍵趨勢包括生物技術和基因工程的進步、藥物傳輸系統的技術進步、研發投資的增加、新型輸送平台的開發以及診斷技術的進步。

基因治療的日益普及預計將推動未來藥物輸送設備市場的擴張。基因治療是一種透過引入、移除或修改患者細胞中的遺傳物質來治療或預防疾病的醫學方法。基因治療的需求不斷成長，因為它有可能從根本上解決遺傳和慢性疾病，並在傳統治療方法不足的地方帶來變革性治療。藥物傳遞裝置在基因治療中發揮著至關重要的作用，透過確保治療基因的精確定位和控制釋放來提高治療效果。例如，美國科學資源機構美國國家生物技術資訊中心在2023年11月預測，接受基因治療的新患者數量將從2020年的16,244人增加到2025年的94,696人。因此，基因治療的普及正在推動藥物輸送裝置市場的成長。

為了獲得競爭優勢，藥物輸送設備市場的主要企業正專注於開發融合人工智慧 (AI) 技術的先進產品。藥物傳輸中的人工智慧技術涉及使用人工智慧技術和演算法來提高輸送系統的效率、準確性和有效性。例如，2023 年 12 月，專門從事標靶遞送聚合物基奈米顆粒的美國公司 Envoya Inc. 宣布推出一種新的基因治療遞送平台。該平台整合了生物聚合物奈米顆粒和人工智慧，以解決當前基因治療技術的關鍵局限性，例如病毒載體和脂質奈米顆粒。目的是克服基因治療傳遞系統中現有的有關安全性、有效載荷能力和組織靶向性的挑戰。

目錄

第1章執行摘要

第2章 市場特徵

第3章 市場趨勢與策略

第4章 市場 - 宏觀經濟情景，包括利率、感染疾病、地緣政治、新冠疫情、經濟復甦對市場的影響

第5章 全球成長分析與策略分析框架

  • 全球藥物輸送設備 PESTEL 分析（政治、社會、技術、環境、法律因素、促進因素和限制因素）
  • 最終用途產業分析
  • 全球藥物輸送設備市場：成長率分析
  • 全球藥物傳輸設備市場表現：規模與成長，2019-2024
  • 全球藥物傳輸設備市場預測：規模與成長，2024-2029 年，2034 年
  • 藥物輸送設備的全球總目標市場（TAM）

第6章市場區隔

  • 全球藥物傳輸設備市場（依載體）：2019-2024 年、2024-2029 年、2034 年實際資料及預測
  • 病毒性的
  • 非病毒
  • 全球藥物傳輸設備市場：依方法、效能與預測，2019-2024 年、2024-2029 年、2034 年
  • 現場
  • 體外
  • 全球給藥裝置市場（依給藥途徑）：2019-2024 年、2024-2029 年、2034 年表現與預測
  • 口服
  • 吸入
  • 經皮
  • 注射
  • 眼科
  • 鼻腔
  • 話題
  • 全球藥物傳輸設備市場，按病毒類型、性能和預測細分，2019-2024 年、2024-2029 年、2034 年
  • 腺病毒載體
  • 慢病毒載體
  • 腺結合病毒（AAV）載體
  • 單純皰疹病毒（HSV）載體
  • 逆轉錄病毒載體
  • 桿狀病毒載體
  • 痘苗病毒載體
  • 仙台病毒載體
  • 全球藥物傳輸設備市場非病毒細分市場，依類型、績效及預測，2019-2024 年、2024-2029 年、2034 年
  • 脂質奈米顆粒（LNP）
  • 聚合物奈米粒子
  • 脂質體
  • 樹狀聚合物
  • 裸露DNA/RNA遞送
  • 電穿孔輸送系統
  • 基於奈米顆粒的遞送系統
  • 聚合物膠束和水凝膠

第7章 區域和國家分析

  • 全球藥物傳輸設備市場：按地區、績效及預測，2019-2024 年、2024-2029 年、2034 年
  • 全球藥物輸送裝置市場：依國家、績效及預測，2019-2024 年、2024-2029 年、2034 年

第8章 亞太市場

第9章：中國市場

第10章 印度市場

第11章 日本市場

第12章 澳洲市場

第13章 印尼市場

第14章 韓國市場

第15章 西歐市場

第16章英國市場

第17章 德國市場

第18章 法國市場

第19章：義大利市場

第20章：西班牙市場

第21章 東歐市場

第22章 俄羅斯市場

第23章 北美市場

第24章美國市場

第25章：加拿大市場

第26章 南美洲市場

第27章：巴西市場

第28章 中東市場

第29章：非洲市場

第30章競爭格局與公司概況

  • 藥物輸送設備市場：競爭格局
  • 藥物輸送設備市場：公司簡介
    • Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
    • AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis
    • Bayer AG Overview, Products and Services, Strategy and Financial Analysis
    • AstraZeneca plc Overview, Products and Services, Strategy and Financial Analysis
    • Medtronic plc Overview, Products and Services, Strategy and Financial Analysis

第31章 其他大型創新企業

  • Amgen Inc.
  • Moderna Inc.
  • Biogen Inc.
  • Sarepta Therapeutics Inc.
  • SCIEX
  • Halozyme Therapeutics Inc.
  • ViiV Healthcare Limited
  • Uniqure NV
  • Cytokinetics Inc.
  • Prothena Corporation plc
  • Intellia Therapeutics Inc.
  • Voyager Therapeutics Inc.
  • sfm medical devices GmbH
  • Inovio Pharmaceuticals Inc.
  • GenSight Biologics SA

第 32 章全球市場競爭基準化分析與儀表板

第33章 重大併購

第34章近期市場趨勢

第 35 章 高市場潛力國家、細分市場與策略

  • 2029年藥物輸送設備市場：提供新機會的國家
  • 2029年藥物輸送設備市場：細分市場帶來新機會
  • 2029年藥物傳輸設備市場：成長策略
    • 基於市場趨勢的策略
    • 競爭對手的策略

第36章 附錄

簡介目錄
Product Code: r31796

Drug and gene delivery devices are specialized tools designed to transport pharmaceuticals or genetic material into the body for therapeutic purposes. These devices enable targeted treatment of diseases at the molecular level, enhancing precision and efficacy. They play a vital role in advancing personalized medicine by ensuring controlled release and optimal delivery of therapeutic agents to specific cells or tissues, thereby minimizing side effects and maximizing treatment effectiveness.

The main vector types for drug and gene delivery devices include viral and non-viral vectors. Viral gene delivery involves the use of genetically engineered viruses to introduce therapeutic genes into target cells. These methods can be performed in situ (directly within the body) or ex vivo (outside the body, followed by reintroduction). The routes of administration for these devices include oral, inhalation, transdermal, injectable, ocular, nasal, and topical methods.

The drug and gene delivery devices market research report is one of a series of new reports from The Business Research Company that provides drug and gene delivery devices market statistics, including drug and gene delivery devices industry global market size, regional shares, competitors with a drug and gene delivery devices market share, detailed drug and gene delivery devices market segments, market trends and opportunities, and any further data you may need to thrive in the drug and gene delivery devices industry. This drug and gene delivery devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The drug and gene delivery devices market size has grown strongly in recent years. It will grow from $0.61 $ billion in 2024 to $0.67 $ billion in 2025 at a compound annual growth rate (CAGR) of 9.0%. The growth in the historic period can be attributed to healthcare infrastructure development, expansion of personalized gene therapy programs, increasing focus on preventive healthcare, rare and orphan diseases, and increasing public awareness about health and treatment options.

The drug and gene delivery devices market size is expected to see strong growth in the next few years. It will grow to $0.93 $ billion in 2029 at a compound annual growth rate (CAGR) of 8.7%. The growth in the forecast period can be attributed to the increasing incidence of chronic diseases, growing demand for personalized medicine, increasing awareness and adoption of gene therapy, demand for non-invasive and minimally invasive procedures, and the growing popularity of direct-to-patient delivery models. Major trends in the forecast period include advancements in biotechnology and genetic engineering, technological advancements in drug delivery systems, increasing investment in research and development, the development of novel delivery platforms, and advancements in diagnostic technologies.

The growing adoption of gene therapy is anticipated to drive the expansion of the drug and gene delivery devices market in the future. Gene therapy is a medical approach that involves introducing, removing, or altering genetic material within a patient's cells to treat or prevent diseases. The increasing demand for gene therapy stems from its potential to address genetic disorders and chronic diseases at their source, providing transformative treatment options where conventional therapies may fall short. Drug and gene delivery devices play a crucial role in gene therapy by ensuring precise targeting and controlled release of therapeutic genes, which enhances the effectiveness of treatments. For example, in November 2023, the National Centre for Biotechnology Information, a US-based scientific resource, projected that the number of new patients receiving gene therapies would rise from 16,244 in 2020 to 94,696 by 2025. Thus, the growing adoption of gene therapy is fueling the growth of the drug and gene delivery devices market.

Leading companies in the drug and gene delivery devices market are concentrating on developing advanced products, including artificial intelligence (AI) technology, to secure a competitive advantage. In drug delivery, AI technology involves using AI techniques and algorithms to enhance the efficiency, precision, and effectiveness of delivery systems. For instance, in December 2023, Envoya Inc., a US-based company specializing in polymer-based nanoparticles for targeted delivery, introduced a new gene therapy drug delivery platform. This platform integrates biopolymer nanoparticles with AI to address key limitations of current gene therapy technologies, such as viral vectors and lipid nanoparticles. The goal is to overcome existing challenges related to safety, payload capacity, and tissue targeting in gene therapy delivery systems.

In March 2022, Sandoz Group AG, a Switzerland-based pharmaceutical company, acquired Coalesce Product Development Limited for an undisclosed amount. This acquisition was aimed at enhancing Sandoz's portfolio of respiratory medicines and improving patient access to high-quality, complex therapies. Coalesce Product Development Limited is a UK-based company specializing in medical and drug delivery devices.

Major companies operating in the drug and gene delivery devices market are Merck & Co. Inc., AbbVie Inc., Bayer AG, AstraZeneca plc, Medtronic plc, Amgen Inc., Moderna Inc., Biogen Inc., Sarepta Therapeutics Inc., SCIEX, Halozyme Therapeutics Inc., ViiV Healthcare Limited, Uniqure NV, Cytokinetics Inc., Prothena Corporation plc, Intellia Therapeutics Inc., Voyager Therapeutics Inc., sfm medical devices GmbH, Inovio Pharmaceuticals Inc., GenSight Biologics S.A., CRISPR Therapeutics

North America was the largest region in the drug and gene delivery devices market in 2023. The regions covered in the drug and gene delivery devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the drug and gene delivery devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The drug and gene delivery devices market consists of sales of microspheres and microneedles, electroporation devices, bioadhesive systems, and gene therapy vectors. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Drug And Gene Delivery Devices Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on drug and gene delivery devices market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for drug and gene delivery devices ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The drug and gene delivery devices market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Vector: Viral; Non-viral
  • 2) By Method: In Situ; Ex Vivo
  • 3) By Route Of Administration: Oral; Inhalation; Transdermal; Injectable; Ocular; Nasal; Topical
  • Subsegments:
  • 1) By Viral: Adenovirus Vectors; Lentivirus Vectors; Adeno-Associated Virus (AAV) Vectors; Herpes Simplex Virus (HSV) Vectors; Retrovirus Vectors; Baculovirus Vectors; Vaccinia Virus Vectors; Sendai Virus Vectors
  • 2) By Non-Viral: Lipid Nanoparticles (LNP); Polymeric Nanoparticles; Liposomes; Dendrimers; Naked DNA/RNA Delivery; Electroporation-Based Delivery Systems; Nanoparticle-Based Delivery Systems; Polymer Micelles And Hydrogels.
  • Companies Mentioned: Merck & Co. Inc.; AbbVie Inc.; Bayer AG; AstraZeneca plc; Medtronic plc
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Drug And Gene Delivery Devices Market Characteristics

3. Drug And Gene Delivery Devices Market Trends And Strategies

4. Drug And Gene Delivery Devices Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market

5. Global Drug And Gene Delivery Devices Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Drug And Gene Delivery Devices PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Drug And Gene Delivery Devices Market Growth Rate Analysis
  • 5.4. Global Drug And Gene Delivery Devices Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Drug And Gene Delivery Devices Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Drug And Gene Delivery Devices Total Addressable Market (TAM)

6. Drug And Gene Delivery Devices Market Segmentation

  • 6.1. Global Drug And Gene Delivery Devices Market, Segmentation By Vector, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Viral
  • Non-viral
  • 6.2. Global Drug And Gene Delivery Devices Market, Segmentation By Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • In Situ
  • Ex Vivo
  • 6.3. Global Drug And Gene Delivery Devices Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Oral
  • Inhalation
  • Transdermal
  • Injectable
  • Ocular
  • Nasal
  • Topical
  • 6.4. Global Drug And Gene Delivery Devices Market, Sub-Segmentation Of Viral, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Adenovirus Vectors
  • Lentivirus Vectors
  • Adeno-Associated Virus (AAV) Vectors
  • Herpes Simplex Virus (HSV) Vectors
  • Retrovirus Vectors
  • Baculovirus Vectors
  • Vaccinia Virus Vectors
  • Sendai Virus Vectors
  • 6.5. Global Drug And Gene Delivery Devices Market, Sub-Segmentation Of Non-Viral, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Lipid Nanoparticles (LNP)
  • Polymeric Nanoparticles
  • Liposomes
  • Dendrimers
  • Naked DNA/RNA Delivery
  • Electroporation-Based Delivery Systems
  • Nanoparticle-Based Delivery Systems
  • Polymer Micelles And Hydrogels

7. Drug And Gene Delivery Devices Market Regional And Country Analysis

  • 7.1. Global Drug And Gene Delivery Devices Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Drug And Gene Delivery Devices Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Drug And Gene Delivery Devices Market

  • 8.1. Asia-Pacific Drug And Gene Delivery Devices Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Drug And Gene Delivery Devices Market, Segmentation By Vector, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Drug And Gene Delivery Devices Market, Segmentation By Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Drug And Gene Delivery Devices Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Drug And Gene Delivery Devices Market

  • 9.1. China Drug And Gene Delivery Devices Market Overview
  • 9.2. China Drug And Gene Delivery Devices Market, Segmentation By Vector, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Drug And Gene Delivery Devices Market, Segmentation By Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Drug And Gene Delivery Devices Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Drug And Gene Delivery Devices Market

  • 10.1. India Drug And Gene Delivery Devices Market, Segmentation By Vector, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Drug And Gene Delivery Devices Market, Segmentation By Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Drug And Gene Delivery Devices Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Drug And Gene Delivery Devices Market

  • 11.1. Japan Drug And Gene Delivery Devices Market Overview
  • 11.2. Japan Drug And Gene Delivery Devices Market, Segmentation By Vector, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Drug And Gene Delivery Devices Market, Segmentation By Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Drug And Gene Delivery Devices Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Drug And Gene Delivery Devices Market

  • 12.1. Australia Drug And Gene Delivery Devices Market, Segmentation By Vector, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Drug And Gene Delivery Devices Market, Segmentation By Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Drug And Gene Delivery Devices Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Drug And Gene Delivery Devices Market

  • 13.1. Indonesia Drug And Gene Delivery Devices Market, Segmentation By Vector, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Drug And Gene Delivery Devices Market, Segmentation By Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Drug And Gene Delivery Devices Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Drug And Gene Delivery Devices Market

  • 14.1. South Korea Drug And Gene Delivery Devices Market Overview
  • 14.2. South Korea Drug And Gene Delivery Devices Market, Segmentation By Vector, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Drug And Gene Delivery Devices Market, Segmentation By Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Drug And Gene Delivery Devices Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Drug And Gene Delivery Devices Market

  • 15.1. Western Europe Drug And Gene Delivery Devices Market Overview
  • 15.2. Western Europe Drug And Gene Delivery Devices Market, Segmentation By Vector, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Drug And Gene Delivery Devices Market, Segmentation By Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Drug And Gene Delivery Devices Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Drug And Gene Delivery Devices Market

  • 16.1. UK Drug And Gene Delivery Devices Market, Segmentation By Vector, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Drug And Gene Delivery Devices Market, Segmentation By Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Drug And Gene Delivery Devices Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Drug And Gene Delivery Devices Market

  • 17.1. Germany Drug And Gene Delivery Devices Market, Segmentation By Vector, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Drug And Gene Delivery Devices Market, Segmentation By Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Drug And Gene Delivery Devices Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Drug And Gene Delivery Devices Market

  • 18.1. France Drug And Gene Delivery Devices Market, Segmentation By Vector, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Drug And Gene Delivery Devices Market, Segmentation By Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Drug And Gene Delivery Devices Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Drug And Gene Delivery Devices Market

  • 19.1. Italy Drug And Gene Delivery Devices Market, Segmentation By Vector, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Drug And Gene Delivery Devices Market, Segmentation By Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Drug And Gene Delivery Devices Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Drug And Gene Delivery Devices Market

  • 20.1. Spain Drug And Gene Delivery Devices Market, Segmentation By Vector, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Drug And Gene Delivery Devices Market, Segmentation By Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Drug And Gene Delivery Devices Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Drug And Gene Delivery Devices Market

  • 21.1. Eastern Europe Drug And Gene Delivery Devices Market Overview
  • 21.2. Eastern Europe Drug And Gene Delivery Devices Market, Segmentation By Vector, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Drug And Gene Delivery Devices Market, Segmentation By Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Drug And Gene Delivery Devices Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Drug And Gene Delivery Devices Market

  • 22.1. Russia Drug And Gene Delivery Devices Market, Segmentation By Vector, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Drug And Gene Delivery Devices Market, Segmentation By Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Drug And Gene Delivery Devices Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Drug And Gene Delivery Devices Market

  • 23.1. North America Drug And Gene Delivery Devices Market Overview
  • 23.2. North America Drug And Gene Delivery Devices Market, Segmentation By Vector, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Drug And Gene Delivery Devices Market, Segmentation By Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Drug And Gene Delivery Devices Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Drug And Gene Delivery Devices Market

  • 24.1. USA Drug And Gene Delivery Devices Market Overview
  • 24.2. USA Drug And Gene Delivery Devices Market, Segmentation By Vector, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Drug And Gene Delivery Devices Market, Segmentation By Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Drug And Gene Delivery Devices Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Drug And Gene Delivery Devices Market

  • 25.1. Canada Drug And Gene Delivery Devices Market Overview
  • 25.2. Canada Drug And Gene Delivery Devices Market, Segmentation By Vector, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Drug And Gene Delivery Devices Market, Segmentation By Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Drug And Gene Delivery Devices Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Drug And Gene Delivery Devices Market

  • 26.1. South America Drug And Gene Delivery Devices Market Overview
  • 26.2. South America Drug And Gene Delivery Devices Market, Segmentation By Vector, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Drug And Gene Delivery Devices Market, Segmentation By Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Drug And Gene Delivery Devices Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Drug And Gene Delivery Devices Market

  • 27.1. Brazil Drug And Gene Delivery Devices Market, Segmentation By Vector, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Drug And Gene Delivery Devices Market, Segmentation By Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Drug And Gene Delivery Devices Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Drug And Gene Delivery Devices Market

  • 28.1. Middle East Drug And Gene Delivery Devices Market Overview
  • 28.2. Middle East Drug And Gene Delivery Devices Market, Segmentation By Vector, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Drug And Gene Delivery Devices Market, Segmentation By Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Drug And Gene Delivery Devices Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Drug And Gene Delivery Devices Market

  • 29.1. Africa Drug And Gene Delivery Devices Market Overview
  • 29.2. Africa Drug And Gene Delivery Devices Market, Segmentation By Vector, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Drug And Gene Delivery Devices Market, Segmentation By Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Drug And Gene Delivery Devices Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Drug And Gene Delivery Devices Market Competitive Landscape And Company Profiles

  • 30.1. Drug And Gene Delivery Devices Market Competitive Landscape
  • 30.2. Drug And Gene Delivery Devices Market Company Profiles
    • 30.2.1. Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. Bayer AG Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. AstraZeneca plc Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. Medtronic plc Overview, Products and Services, Strategy and Financial Analysis

31. Drug And Gene Delivery Devices Market Other Major And Innovative Companies

  • 31.1. Amgen Inc.
  • 31.2. Moderna Inc.
  • 31.3. Biogen Inc.
  • 31.4. Sarepta Therapeutics Inc.
  • 31.5. SCIEX
  • 31.6. Halozyme Therapeutics Inc.
  • 31.7. ViiV Healthcare Limited
  • 31.8. Uniqure NV
  • 31.9. Cytokinetics Inc.
  • 31.10. Prothena Corporation plc
  • 31.11. Intellia Therapeutics Inc.
  • 31.12. Voyager Therapeutics Inc.
  • 31.13. sfm medical devices GmbH
  • 31.14. Inovio Pharmaceuticals Inc.
  • 31.15. GenSight Biologics S.A.

32. Global Drug And Gene Delivery Devices Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Drug And Gene Delivery Devices Market

34. Recent Developments In The Drug And Gene Delivery Devices Market

35. Drug And Gene Delivery Devices Market High Potential Countries, Segments and Strategies

  • 35.1 Drug And Gene Delivery Devices Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Drug And Gene Delivery Devices Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Drug And Gene Delivery Devices Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer